344 related articles for article (PubMed ID: 27018234)
1. Ocular Manifestations of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Children.
Catt CJ; Hamilton GM; Fish J; Mireskandari K; Ali A
Am J Ophthalmol; 2016 Jun; 166():68-75. PubMed ID: 27018234
[TBL] [Abstract][Full Text] [Related]
2. Corneal Limbal Stem Cell Deficiency in Children with Stevens-Johnson Syndrome.
Choi SH; Kim MK; Oh JY
Am J Ophthalmol; 2019 Mar; 199():1-8. PubMed ID: 30347185
[TBL] [Abstract][Full Text] [Related]
3. Long-Term Effect of a Treatment Protocol for Acute Ocular Involvement in Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis.
Shanbhag SS; Rashad R; Chodosh J; Saeed HN
Am J Ophthalmol; 2019 Dec; 208():331-341. PubMed ID: 31326519
[TBL] [Abstract][Full Text] [Related]
4. Plasmapheresis, Intravenous Immunoglobulins, and Autologous Serum Eyedrops in the Acute Eye Complications of Toxic Epidermal Necrolysis.
Pinna A; Nuvoli E; Blasetti F; Posadinu MA; Boscia F
Eur J Ophthalmol; 2017 Nov; 27(6):658-663. PubMed ID: 28362052
[TBL] [Abstract][Full Text] [Related]
5. Correlation of corneal complications with eyelid cicatricial pathologies in patients with Stevens-Johnson syndrome and toxic epidermal necrolysis syndrome.
Di Pascuale MA; Espana EM; Liu DT; Kawakita T; Li W; Gao YY; Baradaran-Rafii A; Elizondo A; Raju VK; Tseng SC
Ophthalmology; 2005 May; 112(5):904-12. PubMed ID: 15878074
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of chronic ocular complications in Stevens-Johnson syndrome and toxic epidermal necrolysis.
Van Zyl L; Carrara H; Lecuona K
Middle East Afr J Ophthalmol; 2014; 21(4):332-5. PubMed ID: 25371640
[TBL] [Abstract][Full Text] [Related]
7. Prosthetic replacement of the ocular surface ecosystem as treatment for ocular surface disease in patients with a history of Stevens-Johnson syndrome/toxic epidermal necrolysis.
Papakostas TD; Le HG; Chodosh J; Jacobs DS
Ophthalmology; 2015 Feb; 122(2):248-53. PubMed ID: 25282251
[TBL] [Abstract][Full Text] [Related]
8. Multistep Grading System for Evaluation of Chronic Ocular Sequelae in Patients With Stevens-Johnson Syndrome.
Sharma N; Venugopal R; Maharana PK; Chaniyara M; Agarwal T; Pushker N; Pandey RM; Sangwan S; Sen S; Kashyap S; Sharma A; Khanna N; Vajpayee RB
Am J Ophthalmol; 2019 Jul; 203():69-77. PubMed ID: 30731084
[TBL] [Abstract][Full Text] [Related]
9. New grading system for the evaluation of chronic ocular manifestations in patients with Stevens-Johnson syndrome.
Sotozono C; Ang LP; Koizumi N; Higashihara H; Ueta M; Inatomi T; Yokoi N; Kaido M; Dogru M; Shimazaki J; Tsubota K; Yamada M; Kinoshita S
Ophthalmology; 2007 Jul; 114(7):1294-302. PubMed ID: 17475335
[TBL] [Abstract][Full Text] [Related]
10. Adjuvant Role of Amniotic Membrane Transplantation in Acute Ocular Stevens-Johnson Syndrome: A Randomized Control Trial.
Sharma N; Thenarasun SA; Kaur M; Pushker N; Khanna N; Agarwal T; Vajpayee RB
Ophthalmology; 2016 Mar; 123(3):484-91. PubMed ID: 26686968
[TBL] [Abstract][Full Text] [Related]
11. A cross-sectional comparative study on chronic ocular manifestations of Stevens-Johnson syndrome and toxic epidermal necrolysis in Chinese eyes: a 15-year case series.
Chow LLW; Ng ALK; Chow SSW; Choy BNK; Shih KC; Wong IYH; Chan JCY; Lai JSM
Int Ophthalmol; 2018 Jun; 38(3):1155-1160. PubMed ID: 28547534
[TBL] [Abstract][Full Text] [Related]
12. Chronic Ocular Sequelae of Stevens-Johnson Syndrome in Children: Long-term Impact of Appropriate Therapy on Natural History of Disease.
Basu S; Shanbhag SS; Gokani A; Kedar R; Bahuguna C; Sangwan VS
Am J Ophthalmol; 2018 May; 189():17-28. PubMed ID: 29421293
[TBL] [Abstract][Full Text] [Related]
13. Treatment of acute Stevens-Johnson syndrome and toxic epidermal necrolysis using amniotic membrane: a review of 10 consecutive cases.
Gregory DG
Ophthalmology; 2011 May; 118(5):908-14. PubMed ID: 21440941
[TBL] [Abstract][Full Text] [Related]
14. Lid-Related Keratopathy in Stevens-Johnson Syndrome: Natural Course and Impact of Therapeutic Interventions in Children and Adults.
Shanbhag SS; Shah S; Singh M; Bahuguna C; Donthineni PR; Basu S
Am J Ophthalmol; 2020 Nov; 219():357-365. PubMed ID: 32681905
[TBL] [Abstract][Full Text] [Related]
15. Ophthalmic Manifestations of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis and Relation to SCORTEN.
Morales ME; Purdue GF; Verity SM; Arnoldo BD; Blomquist PH
Am J Ophthalmol; 2010 Oct; 150(4):505-510.e1. PubMed ID: 20619392
[TBL] [Abstract][Full Text] [Related]
16. The role of systemic immunomodulatory treatment and prognostic factors on chronic ocular complications in Stevens-Johnson syndrome.
Kim DH; Yoon KC; Seo KY; Lee HS; Yoon SC; Sotozono C; Ueta M; Kim MK
Ophthalmology; 2015 Feb; 122(2):254-64. PubMed ID: 25262319
[TBL] [Abstract][Full Text] [Related]
17. Long-term Progression of Ocular Surface Disease in Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis.
Yoshikawa Y; Ueta M; Fukuoka H; Inatomi T; Yokota I; Teramukai S; Yokoi N; Kinoshita S; Tajiri K; Ikeda T; Sotozono C
Cornea; 2020 Jun; 39(6):745-753. PubMed ID: 32028281
[TBL] [Abstract][Full Text] [Related]
18. New Grading System and Treatment Guidelines for the Acute Ocular Manifestations of Stevens-Johnson Syndrome.
Gregory DG
Ophthalmology; 2016 Aug; 123(8):1653-1658. PubMed ID: 27297404
[TBL] [Abstract][Full Text] [Related]
19. Diagnosis and treatment of Stevens-Johnson syndrome and toxic epidermal necrolysis with ocular complications.
Sotozono C; Ueta M; Koizumi N; Inatomi T; Shirakata Y; Ikezawa Z; Hashimoto K; Kinoshita S
Ophthalmology; 2009 Apr; 116(4):685-90. PubMed ID: 19243825
[TBL] [Abstract][Full Text] [Related]
20. Prosthetic Replacement of the Ocular Surface Ecosystem Treatment for Ocular Surface Disease in Pediatric Patients With Stevens-Johnson Syndrome.
Wang Y; Rao R; Jacobs DS; Saeed HN
Am J Ophthalmol; 2019 May; 201():1-8. PubMed ID: 30664843
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
